NCT01793103View on ClinicalTrials.gov

Brigham and Women's Rheumatoid Arthritis Sequential Study

Active, not recruitingOBSERVATIONAL
Enrollment

1,598

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2028

Conditions
Rheumatoid Arthritis
Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

Sponsors
All Listed Sponsors
collaborator

Crescendo Bioscience

INDUSTRY

collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

UCB Pharma

INDUSTRY

collaborator

Sanofi

INDUSTRY

collaborator

Janssen, LP

INDUSTRY

collaborator

Aqtual, Inc.

INDUSTRY

lead

Brigham and Women's Hospital

OTHER